PureCycle Technologies (PCT) has opened 2026 with Q1 revenue of US$4.1 million, a basic EPS loss of US$0.19 and a net loss of US$33.4 million, setting a clear tone for how the year is starting to shape up for shareholders. The company has seen quarterly revenue move from US$1.6 million in Q1 2025 to US$4.1 million in Q1 2026, while basic EPS has swung from a profit of US$0.05 to a loss of US$0.19, so the latest print keeps margins under pressure even as the top line scales.

See our full analysis for PureCycle Technologies.

With the headline numbers on the table, the next step is to see how this earnings profile lines up against the key PureCycle narratives that investors have been following over the past year and where those stories may need updating.

US$33.4m loss keeps margins deeply negative

• Q1 2026 net loss came in at US$33.4 million on US$4.1 million of revenue, which means the company is still burning a lot of cash relative to its current sales base.
• Bears highlight that trailing 12 month losses sit at US$224.8 million and have grown at about 29.5% per year over the past five years. This backdrop
  • fits with the Q1 pattern where basic EPS was a loss of US$0.19, compared with a trailing 12 month EPS loss of US$1.25, keeping the business firmly in loss making territory, and
  • lines up with the view that PureCycle is not forecast to be profitable over the next three years, so near term quarterly results are still about managing the size of losses rather than delivering positive earnings.

Stay grounded in the numbers by seeing how skeptics frame this widening loss profile against future expectations in the 🐻 PureCycle Technologies Bear Case.

Revenue ramp to US$10.9m over the last year

• On a trailing 12 month basis, revenue reached US$10.9 million by Q1 2026, up from US$1.6 million in Q1 2025 for the quarter, so the business is now generating sales rather than just pre revenue results.
• Bulls point to very high forecast revenue growth of 54.24% per year and even higher analyst scenario assumptions. This Q1 print
  • shows quarterly revenue at US$4.1 million compared with US$2.7 million in Q4 2025 and US$0 in Q4 2024, which supports the bullish focus on production ramp and commercial uptake, while
  • also reminding you that trailing 12 month net income is still a loss of US$224.8 million, so any growth case has to be weighed against sizeable ongoing losses.

See how bullish investors connect this early revenue ramp to their long term growth story in the 🐂 PureCycle Technologies Bull Case.

Rich P/B multiple with short cash runway

• The stock is described as trading around 30x P/B versus roughly 2.6x for peers and 1.6x for the broader US Chemicals industry, while the company is unprofitable and has less than one year of cash runway.
• Critics argue this combination makes the shares vulnerable. The recent data
  • show trailing 12 month revenue of US$10.9 million against a trailing 12 month net loss of US$224.8 million, which leaves little internal funding capacity, and
  • sit alongside higher than market share price volatility over the past three months, meaning any changes to financing plans or operating performance can have an amplified effect on the stock.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for PureCycle Technologies on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Does this mix of pressure and potential match your own read of the stock, or is it sending a different signal? Act while the details are fresh and test the story against the numbers by reviewing the 1 key reward and 3 important warning signs.

See What Else Is Out There

PureCycle is still running deep losses, has a short cash runway and trades on a rich P/B multiple. Together, these factors raise questions about funding and downside risk.

If you want stocks where balance sheets help cushion those kinds of risks, start comparing ideas in the solid balance sheet and fundamentals stocks screener (45 results) today while this update is top of mind.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.